Axogen, Inc. (AXGN) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
AXGN currently has 51.6M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 17.18% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 28, 2026 |
10-Q filing | 51.6M shares outstanding |
52M | 0 |
| Jan 23, 2026 |
8-K filing: Axogen, Inc. entered into an underwriting agreement to sell 4,000,000 shares of its common stock at a public offering price of $31.00 per share, with an option for the underwriters to purchase an additional 600,000 shares; the closing is expected on January 23, 2026 and proceeds may be used to pay off debt. ($124.0M proceeds) |
46M | 0 |
| Oct 29, 2025 |
10-Q filing | 46.5M shares outstanding |
46M | 0 |
| Aug 05, 2025 |
10-Q filing | 46.1M shares outstanding |
46M | 0 |
| May 08, 2025 |
10-Q filing | 45.2M shares outstanding |
45M | 0 |
| Feb 26, 2025 |
10-K filing | 44.3M shares outstanding |
44M | 0 |
| Nov 07, 2024 |
10-Q filing | 43.9M shares outstanding |
44M | 0 |
| Aug 08, 2024 |
10-Q filing | 43.7M shares outstanding |
44M | 0 |
| May 02, 2024 |
10-Q filing | 43.2M shares outstanding |
43M | 0 |
| Mar 29, 2024 |
S-3/A filing: The company may offer and sell up to $100,000,000 in the aggregate of any combination of common stock, preferred stock, and/or debt securities. |
43M | 0 |
| Mar 06, 2024 |
POS AM filing: This is a post-effective amendment to a registration statement on Form S-3 for Axogen, Inc., relating to a shelf offering of common stock. |
43M | 0 |
| Mar 06, 2024 |
S-3 filing: This is an S-3 filing for a shelf offering of up to $100,000,000 in the aggregate of any combination of common stock, preferred stock and debt securities. |
43M | 0 |
| Mar 05, 2024 |
10-K filing | 42.9M shares outstanding |
43M | 0 |
| Nov 07, 2023 |
10-Q filing | 43.0M shares outstanding |
43M | 0 |
| Aug 08, 2023 |
10-Q filing | 42.9M shares outstanding |
43M | 0 |
| May 09, 2023 |
10-Q filing | 42.6M shares outstanding |
43M | 0 |
| Mar 14, 2023 |
10-K filing | 42.1M shares outstanding |
42M | 0 |
| Nov 08, 2022 |
10-Q filing | 42.2M shares outstanding |
42M | 0 |
| Aug 05, 2022 |
10-Q filing | 42.0M shares outstanding |
42M | 0 |
| May 05, 2022 |
10-Q filing | 41.8M shares outstanding |
42M | 0 |
| Feb 25, 2022 |
POS AM filing: Axogen may offer and sell up to $100,000,000 in the aggregate of common stock from time to time in amounts, at prices and on terms described in one or more supplements to this prospectus. |
41M | 0 |
| Feb 25, 2022 |
10-K filing | 41.2M shares outstanding |
41M | 250K |
| Nov 04, 2021 |
10-Q filing | 41.5M shares outstanding |
41M | 0 |
| Aug 05, 2021 |
10-Q filing | 41.1M shares outstanding |
41M | 0 |
| May 06, 2021 |
10-Q filing | 41.0M shares outstanding |
41M | 0 |
| Mar 01, 2021 |
10-K filing | 40.7M shares outstanding |
41M | 0 |
| Jan 14, 2021 |
8-K filing: Axogen, Inc. filed a prospectus supplement to the Registration Statement covering the resale of up to 247,699 shares of the Company's Common Stock by the selling stockholder. |
40M | 0 |
| Oct 30, 2020 |
10-Q filing | 40.1M shares outstanding |
40M | 0 |
| Aug 07, 2020 |
10-Q filing | 40.0M shares outstanding |
40M | 0 |
| May 06, 2020 |
10-Q filing | 39.7M shares outstanding |
40M | 0 |
| Feb 24, 2020 |
10-K filing | 39.6M shares outstanding |
40M | 0 |